SunBird Bio, Inc. — Form D/A

SunBird Bio, Inc. of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2021-07-01. The offering totals $46.7M, of which $46.7M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (24)

NameRoleLocation
Alexandra CantleyDirectorNewton, MA
Amy SchulmanDirectorCambridge, MA
Robert LangerDirectorPittsburgh, PA
Stanley LapidusDirectorBOSTON, MA
Steve KafkaDirectorSan Mateo, CA
John McDonoughDirectorNew York, NY
Sirshendu Roopom BanerjeeExecutive OfficerWoburn, MA
Theresia GouwDirectorSan Francisco, CA
YINGMIN WANGDirectorCAMBRIDGE, MA
HUILIN SHAODirectorCAMBRIDGE, MA
George ZacharyDirectorSan Francisco, CA
Caroline LoewDirectorBoston, MA
Caroline LoewExecutive OfficerBoston, MA
Francis CussDirectorCambridge, MA
Tram Winckler TranExecutive OfficerCambridge, MA
Wendy Winckler AdamovichExecutive OfficerCambridge, MA
Jessica Winckler AtkinsonExecutive OfficerCambridge, MA
Dhaval Winckler GosaliaExecutive OfficerCambridge, MA
Matthew Winckler NavarroExecutive OfficerCambridge, MA
Tracey DawsonExecutive OfficerCambridge, MA
Theresia Roopom GuowDirectorCambridge, MA
Gabriel KwongExecutive OfficerCambridge, MA
Stan Roopom LapidusDirectorCambridge, MA
Amy Roopom SchulmanDirectorCambridge, MA

Other filings by this issuer (4)

FiledFormOfferingSold
2023-05-12D$23.2M$23.2M
2021-12-17D$18.0M$18.0M
2020-06-12D$45.0M$26.1M
2018-08-06D$30.1M$26.1M

More